Menendez slams Hugin for discounting drugs in Russia

PENNINGTON - U.S. Senator Bob Menendez today called Bob Hugin’s decision to sell a life-saving cancer drug in Russia for almost half the U.S. price “outrageous” and “despicable.” The comments by the New Jersey Democrat came a day after NJ.com reported that Celgene, the pharmaceutical company Hugin ran, cut the price of Revlimid by about 45% in Russia while raising the cost of the same drug in the United States

Ex-rival vouches for Hugin’s pro-life credentials

A longtime New Jersey pro-life advocate says that he’s satisfied with U.S. Senate candidate Bob Hugin’s position on abortion. “I know that he opposes late term abortion and will support any judges proposed by President Trump,” said Richard Pezzullo, who dropped out of the race this week to endorse Hugin. The Hugin campaign clarified Pezzullo’s depiction on the new candidate’s views. “Bob opposes late-term abortions unless the life of the mother